Previous Article | Next Article 
Journal of Bacteriology, December 2008, p. 7621-7632, Vol. 190, No. 23
0021-9193/08/$08.00+0 doi:10.1128/JB.00806-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Tricarboxylic Acid Cycle-Dependent Regulation of Staphylococcus epidermidis Polysaccharide Intercellular Adhesin Synthesis
,
Marat R. Sadykov,1
Michael E. Olson,2
Steven Halouska,3
Yefei Zhu,1
Paul D. Fey,2
Robert Powers,3 and
Greg A. Somerville1*
Department of Veterinary and Biomedical Sciences, University of Nebraska—Lincoln, Lincoln, Nebraska 68583-0905,1
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198-6280,2
Department of Chemistry, University of Nebraska—Lincoln, Lincoln, Nebraska 68522-03043
Received 9 June 2008/
Accepted 21 September 2008

ABSTRACT
Staphylococcus epidermidis is a major nosocomial pathogen primarily
infecting immunocompromised individuals or those with implanted
biomaterials (e.g., catheters). Biomaterial-associated infections
often involve the formation of a biofilm on the surface of the
medical device. In
S. epidermidis, polysaccharide intercellular
adhesin (PIA) is an important mediator of biofilm formation
and pathogenesis. Synthesis of PIA is regulated by at least
three DNA binding proteins (IcaR, SarA, and
B) and several environmental
and nutritional conditions. Previously, we observed the environmental
conditions that increased PIA synthesis decreased tricarboxylic
acid (TCA) cycle activity. In this study,
S. epidermidis TCA
cycle mutants were constructed, and the function of central
metabolism in PIA biosynthesis was examined. TCA cycle inactivation
altered the metabolic status of
S. epidermidis, resulting in
a massive derepression of PIA biosynthetic genes and a redirection
of carbon from growth into PIA biosynthesis. These data demonstrate
that the bacterial metabolic status is a critical regulatory
determinant of PIA synthesis. In addition, these data lead us
to propose that the TCA cycle acts as a signal transduction
pathway to translate external environmental cues into intracellular
metabolic signals that modulate the activity of transcriptional
regulators.

INTRODUCTION
Staphylococcus epidermidis is the most frequently isolated nosocomial
pathogen from the blood cultures of adult and pediatric intensive
care unit patients in the United States of America (
48). Frequently,
S. epidermidis infections involve the formation of a biofilm
on the surfaces of biomaterials (e.g., catheters) (
77). A biofilm
is a complex aggregation of bacteria usually encapsulated by
an adhesive exopolysaccharide matrix. The exopolysaccharide
matrix provides structural stability to the biofilm, enhanced
adhesion to surfaces, and protection from host defenses and
antibiotics (
2,
50,
79). In
S. epidermidis, the exopolysaccharide
facilitating bacterial adherence in a biofilm is polysaccharide
intercellular adhesin (PIA). PIA is an
N-acetylglucosamine polymer
(
44) of at least 130 residues (
42) whose synthesis requires
the enzymes encoded by genes in the intercellular adhesin (
ica)
operon (
icaADBC) (
27). The synthesis of PIA is required for
the maturation of biofilms (
27), important for evasion of the
host innate immune system (
79,
80), and critical in biomaterial-associated
infections (
55,
57).
Bacteria live in environments subject to rapid changes in the availability of the nutrients necessary to provide energy and biosynthetic intermediates for the synthesis of macromolecules. Consequently, bacterial survival depends on the ability to regulate expression of genes coding for enzymes required for growth in the altered environment. In pathogenic bacteria, adaptation to an altered environment often includes activating transcription of virulence genes; hence, synthesis of many virulence determinants is regulated by environmental/nutritional signals (e.g., nitrogen, iron, and calcium) (47). Because PIA is the most important virulence determinant of S. epidermidis (2, 7, 38, 56, 57, 84), it is not surprising that PIA synthesis is regulated by environmental and nutritional signals (13, 16, 18, 22, 53).
Regulation of the icaADBC operon is complex, involving at least two DNA binding proteins (IcaR and SarA) and the alternative sigma factor
B. IcaR binds immediately 5' to the icaA transcriptional start site and represses transcription of the ica operon (9, 29). SarA is an essential positive effector of icaADBC transcription that binds to the icaA promoter region (26, 74).
B affects PIA synthesis indirectly by regulating the expression of icaR (34, 35, 52). In addition, the luxS quorum-sensing system has a minimal effect on PIA synthesis and biofilm formation; however, the mechanism remains to be determined (82).
In Staphylococcus aureus,
B is activated during stress conditions and growth phase transitions (3, 81). Because S. epidermidis icaADBC transcription and PIA synthesis are induced by environmental and nutritional stresses, stress-dependent activation of
B has been a focal point of research into the environmental regulation of PIA synthesis and biofilm formation (10, 26, 35). Importantly,
B does not respond directly to environmental signals; therefore, a second area of research interest has focused on identifying the regulatory network controlling
B activation, which is involved in responding to environmental signals. The activation of
B involves an anti-sigma factor (RsbW) and an anti-anti-sigma factor (RsbV) and resembles the process in the closely related organism Bacillus subtilis (35). In the absence of environmental stimuli,
B is bound in a complex with RsbW. Stress-inducing stimuli are hypothesized to activate the RsbU phosphatase to dephosphorylate (activate) the anti-anti-sigma factor RsbV, which then binds RsbW in a competitive manner to increase the concentration of free
B (34, 35). Based on several published studies, it seems likely that the
B posttranslational regulatory network is responsible for responding to some environmental stresses (i.e., osmotic stress) but is only minimally involved in responding to nutritional signals (e.g., glucose), suggesting that there are other means for S. epidermidis to "sense" nutritional signals (18, 35, 52).
Previously, we observed the environmental and nutritional signals that enhance PIA synthesis also repress tricarboxylic acid (TCA) cycle activity, leading us to hypothesize that repression of TCA cycle activity would increase PIA accumulation (78). To test this hypothesis, we incubated S. epidermidis strain 1457 with very low concentrations of fluorocitrate, which minimally inhibited TCA cycle activity, and determined the amount of cell-associated PIA. As the concentration of fluorocitrate in the culture medium was increased, the amount of PIA produced increased proportionally (78). Fluorocitrate is a highly toxic compound when metabolized to 4-hydroxy-trans-aconitate by the TCA cycle enzyme aconitase, severely limiting the usable concentration range (40, 46). In the present study, we overcame this limitation by genetically inactivating the aconitase gene in S. epidermidis strain 1457. The aconitase mutant and complemented strains permitted a detailed analysis of the function of central metabolism in PIA synthesis.

MATERIALS AND METHODS
Bacterial strains, bacteriophage, plasmids, and growth conditions.
Bacterial strains, bacteriophage, and plasmids used in this
study are listed in Table
1.
S. epidermidis strain 1457 (
43)
was used in these studies because it is a known PIA- and biofilm-producing
strain.
Escherichia coli strains were grown in 2
x YT broth or
on 2
x YT agar (
58).
S. aureus and
S. epidermidis strains were
grown in tryptic soy broth without dextrose (TSB; BD Biosciences)
supplemented with 0.25% glucose or on TSB containing 1.5% (wt/vol)
agar.
S. epidermidis cultures were inoculated 1:200 from overnight
cultures (normalized for growth) into TSB, incubated at 37°C,
and aerated at 225 rpm with a flask-to-medium ratio of 7:1.
Bacterial growth was assessed by measuring the optical density
at 600 nm or by determining the number of CFU ml
–1. Antibiotics
were purchased from Fisher Scientific or Sigma Chemical and
were used at the following concentrations: ampicillin (100 µg/ml
for
E. coli), chloramphenicol (8 µg/ml), erythromycin
(8 µg/ml), minocycline (2 µg/ml), and trimethoprim
(10 µg/ml).
Staphylococcus epidermidis mutant construction. (i) Aconitase (acnA) mutant.
A 1.7-kb internal PCR product of the
acnA gene of
S. epidermidis strain 1457 was amplified using primers 663 forward (contains
a KasI restriction site) and 664 reverse (contains a PstI restriction
site) (Table
2) and cloned into pGEM-T (Promega). The 1.7-kb
PCR product was excised from pGEM-T by digestion with KasI and
PstI and ligated into the KasI and PstI sites of pUC19 (
83)
to generate the plasmid pNF103. The
tetM cassette from plasmid
pJF12 (from J. Finan and G. Archer) was inserted into a unique
EcoRI site of pNF103 at nucleotide position 856 of the 2,702-bp
acnA gene to generate the pNF117 plasmid. The temperature-sensitive
plasmid pROJ6448 (
51) was digested with PstI and ligated into
the unique PstI site of pNF117. The resulting temperature-sensitive
plasmid pNF118 was passaged through
S. aureus strain RN4220
and introduced into
S. epidermidis strain 1457 by electroporation
(
59). Strain 1457 containing plasmid pNF118 was used to construct
an
acnA::
tetM mutant as described previously (
19). The resulting
mutant was backcrossed into wild-type strain 1457 using transducing
phage 71 (
15). Inactivation of the
acnA gene by
tetM cassette
was verified by PCR, Southern blot analysis (
68), and enzymatic
assays (
64).
(ii) Citrate synthase (citZ) and isocitrate dehydrogenase (citC) double mutant.
The genes coding for citrate synthase and isocitrate dehydrogenase
are present in a two-gene operon and cotranscribed. To inactivate
the
citZC operon, a gene splicing by overlap extension technique
was used to replace a 2-kb internal DNA region of
citZC by the
ermB gene. The
ermB gene was amplified from pEC4 (
5) using primers
citC-r-ermB2 and citZ-f-ermB (Table
2), containing sequences
homologous to the
citC and
citZ genes. Genomic DNA from
S. epidermidis strain 1457 was used as a template for PCR amplification of
the DNA flanking the internal
citZC region. Primers ansP-SacI
and ermB-citZ-r (Table
2) were used for amplification of a 1.9-kb
region of the
citZ upstream region. A 1.7-kb region of the
citC downstream region was amplified using phoP-BamHI and ermB-citC-f2
primers (Table
2). The resulting 4.6-kb PCR product consisted
of a 1-kb
ermB gene with DNA flanking the internal
citZC regions.
The 4.6-kb PCR product contained SacI and BamHI sites that were
used for ligation into pTS1-d digested with SacI and BamHI to
generate pMRS5. The temperature-sensitive plasmid pTS1-d is
a derivative of pTS1 (
24) with deletion of the plasmid-encoded
3' region of the
ermC gene. It was constructed by PCR amplification
of pTS-1 DNA using primers pTS1dErm-f and pTS1dErm-r, and the
resulting PCR product was self-ligated as described previously
(
45). Plasmid pMRS5 was used to construct a strain 1457
citZC double mutant (1457-
citZC::
ermB) (
19). Allelic replacement of
the internal region of
citZC genes by the
ermB cassette was
verified by PCR and Southern blot analysis.
Construction of the complementation plasmid.
Plasmid pCL15 (a kind gift of Chia Lee), containing a Pspac promoter, was used for the construction of an acnA complementation plasmid. The pMRS2 complementation plasmid was constructed by amplifying the 2.7-kb promoterless acnA gene from S. epidermidis strain 1457 using SalI-SD-acnA-f and SacI-acnA-r primers, followed by ligation of the PCR product into plasmid pCL15 digested with SalI and SacI. Plasmid pMRS2 was isolated from S. aureus strain RN4220 and electroporated into S. epidermidis strain 1457 (59). Plasmid pMRS2 was introduced into strain SE1457-acnA using transducing phage 71 (49). Induction of expression from the Pspac promoter was performed by supplementing bacterial cultures with isopropyl-β-D-thiogalactopyranoside (IPTG) (1 mM).
Measurement of acetic acid and glucose concentrations in culture medium.
Aliquots of bacteria (2 ml) were centrifuged for 3 min at 14,000 rpm at 4°C, and the supernatants were removed and stored at –20°C until use. Acetate and glucose concentrations were determined with kits purchased from R-Biopharm and used according to the manufacturer's protocol.
Determination of NAD+, NADH, and ATP concentrations.
Intracellular NAD+ and NADH concentrations were determined with an enzymatic cycling assay kit (Biovision). Briefly, aliquots (5 to 20 ml) were harvested at 2, 3, 4, 5, and 6 h by centrifugation at 4°C for 10 min at 4,000 rpm. Bacterial pellets were suspended in 1 ml of extraction buffer (Biovision) and lysed using lysing matrix B tubes (Qbiogene) in a FastPrep instrument (Qbiogene). The lysate was centrifuged at 4°C for 5 min at 14,000 rpm. NAD+ and NADH concentrations were determined according to the manufacturer's protocol and normalized to the cell density. All assays were performed in duplicate for two independent experiments.
Intracellular ATP concentrations were determined using the Enliten ATP assay (Promega). Briefly, 2 x 107 bacteria were collected at 2, 3, 4, 5, and 6 h, washed three times with 1 ml of phosphate-buffered saline, and suspended in 100 µl of phosphate-buffered saline. Bacteria were lysed by the addition of 900 µl of dimethyl sulfoxide (23). ATP concentrations were determined according to the manufacturer's protocol and normalized to the cell density. All assays were performed in duplicate for two independent experiments.
Determination of aconitase activity.
Cell-free lysates of S. epidermidis were prepared as follows: aliquots of bacteria (2 ml) were harvested by centrifugation and suspended in 750 µl of lysis buffer containing 90 mM Tris (pH 8.0) and 100 µM fluorocitrate. The samples were lysed using lysing matrix B tubes (Qbiogene) in a FastPrep instrument (Qbiogene). The lysate was centrifuged for 5 min at 14,000 rpm and 4°C. Aconitase activity was assayed in the resulting cell-free lysate as previously described (63). One unit of aconitase activity is defined as the amount of enzyme necessary to give a
A240 min–1 of 0.0033 (1). Protein concentrations were determined by the method of Lowry (41).
PIA immunoblot assay.
PIA accumulation was determined as described previously (78). Briefly, TSB medium containing 0.25% glucose was inoculated with equal numbers of bacteria from overnight cultures. The cultures were grown at 37°C, with a flask-to-medium ratio of 7:1, and aerated at 225 rpm. Every 2 h, equal numbers of bacteria (0.25 A600 unit) were harvested by centrifugation, and the PIA was extracted in 0.5 M EDTA (pH 8.0) by boiling for 5 min. Aliquots of PIA were applied to a polyvinylidene difluoride membrane (Immobilon-P; Millipore) and blocked with 5% skim milk overnight. The polyvinylidene difluoride membrane was incubated for 2 h with PIA-specific antiserum (generously provided by Michael Otto), which was followed by a 2-h incubation with an anti-rabbit immunoglobulin G peroxidase conjugate. The presence of PIA was detected using SuperSignal West Pico chemiluminescent substrate (Pierce). The integrated density values of bands on autoradiographs were determined with the TotalLab software (Nonlinear Dynamics Ltd.)
Northern blot analysis.
Northern blot analysis of transcripts was performed as described previously (58), except that total RNA was isolated using the FastRNA Pro Blue kit (Qbiogene) and purified using an RNeasy kit (Qiagen). Oligonucleotide primers (Table 2) used in making DNA probes were designed using the S. epidermidis RP62A genome sequence (GenBank accession number CP000029). Probes for Northern blotting were generated by PCR amplification of unique internal regions of glmM, glmS, glmU, icaD, icaR, pgi, sarA, and sigB genes and labeled using the North2South random prime labeling kit (Pierce). Electrophoresis, transfer of the RNA to the Nytran SPC nylon membrane (Whatman), and hybridization were done using the NorthernMax kit (Ambion). Detection was performed using the chemiluminescent nucleic acid detection module (Pierce). When necessary, reprobing of blots was done according to the manufacturer's protocol.
NMR data collection, processing, and analysis.
Nuclear magnetic resonance (NMR) samples were prepared from three independent cultures (50 ml) of S. epidermidis strains 1457 and 1457-acnA during the exponential growth phase (2 h) and postexponential growth phase (6 h) using [13C6]glucose (Cambridge Isotope Laboratories) in place of glucose in the growth medium. Bacteria were rapidly harvested, lysed using lysing matrix B tubes (Qbiogene) in a FastPrep instrument (Qbiogene), and centrifuged to remove the cell debris. Samples were lyophilized, suspended in a 99.8% D2O (Isotec) 50 mM phosphate buffer, and an aliquot (500 µl) was transferred to an NMR tube for analysis.
The NMR spectra were collected on a Bruker 500-MHz Avance spectrometer equipped with a triple-resonance, z-axis gradient cryoprobe. A BACS-120 sample changer with Bruker Icon software was used to automate the NMR data collection. Two-dimensional (2D) 1H-13C-heteronuclear single quantum coherence (1H-13C-HSQC) spectra were collected with a Bruker pulse sequence (HSQCETGP), solvent presaturation, and relaxation delay of 0.5 s. A total of 1,024 data points with a sweep width of 4734.85 Hz and 64 data points with a sweep width of 13834.26 Hz were collected in the 1H and 13C dimensions, respectively. A total of eight dummy scans and 128 scans were used to obtain each of the 2D 1H-13C HSQC NMR spectra. Spectra were processed using the NMRPipe software package (17) and zero-filled with 2,048 and 1,024 points in the 1H and 13C dimensions, respectively. Additionally, the spectra were Fourier transformed, manually phased, and baseline corrected.
Spectra were analyzed using Primitive Interactive Peak Picker (PIPP) (20) to determine chemical shifts and peak intensities. The chemical shifts were divided into three groups (Tables 3 and 4) based on the intensities of similar peaks between the wild-type and acnA mutant strains during the exponential and postexponential phases of growth. Peak intensities were normalized for each spectrum by dividing by the average peak intensity. The triplicate data sets were then used to calculate average peak intensities for each peak observed in the 2D 1H-13C HSQC spectra for the wild-type and acnA mutant. Similarly, a percent error was calculated for each peak by dividing the standard deviation by the average peak intensity. The average peak intensities were then used to calculate a percent difference between the wild-type and acnA mutant. Peaks with calculated percent differences greater than five times the average percent error were considered to have increased concentrations in the wild-type or acnA mutant strains. Peaks with less than a fivefold deviation were considered similar. The peaks assigned to the same metabolite were required to have the same relative change in intensity in order to be classified as a metabolite with an increase in concentration.
NMR peaks were assigned to specific metabolites using the Madison
Metabolomics Consortium Database (
14) using a tolerance of 0.05
ppm and 0.50 ppm for
1H and
13C dimensions, respectively. The
presence of metabolites and metabolic pathways were verified
with the KEGG (
31) and Metacyc (
32) databases. NMR reference
data available from the Madison Metabolomics Consortium Database
is incomplete, so it is currently not feasible to assign every
NMR resonance observed in the 2D
1H-
13C HSQC NMR spectra to
a
S. epidermidis metabolite. It is also important to note that
the combination of 2D
1H-
13C HSQC NMR spectra with isotopically
enriched (e.g., [
13C
6]glucose) cellular extracts enables the
measurement of accurate metabolite concentration changes relative
to one-dimensional
1H NMR metabolomic methods alone. Generally,
only compounds that are metabolic products of [
13C
6]glucose
were detected.
Statistical analysis.
The statistical significance of changes between wild-type and mutant strains (e.g., ATP concentrations) was assessed with the Student's t test. To determine whether a correlation existed between two physiological parameters, a correlation coefficient (
) was calculated.

RESULTS
Construction and characterization of an S. epidermidis strain 1457 aconitase mutant.
Partial biochemical inhibition of TCA cycle activity in
S. epidermidis increased the accumulation of PIA (
78). Because fluorocitrate
is very toxic, we were unable to completely block TCA cycle
activity without killing the bacteria. To overcome this obstacle,
we inactivated the TCA cycle in
S. epidermidis strain 1457 by
insertion of a
tetM cassette into the gene encoding aconitase
(
acnA; also known as
citB) and then assessed the effect on PIA
synthesis. In
S. epidermidis, aconitase is present as a sole
copy on the chromosome; hence, inactivation of aconitase results
in a nonfunctional TCA cycle. Inactivation of the aconitase
gene in
S. epidermidis strain 1457 by allelic replacement was
genotypically verified by PCR and Southern blot analysis (data
not shown) and phenotypically by aconitase enzymatic activity
assays (Fig.
1A). In addition, overall TCA cycle function was
assessed by measuring the accumulation and depletion of acetic
acid from the culture medium of the wild-type, mutant, and complemented
strains (Fig.
1D). (Acetic acid catabolism in staphylococci
requires a fully functional TCA cycle [
64,
65].) As expected,
aconitase inactivation inhibited the postexponential oxidative
catabolism of acetic acid (Fig.
1D). Of importance, when the
concentration of acetic acid in the culture medium was plotted
as a function of growth, the exponential growth phase rates
of acetic acid accumulation in strains 1457 and 1457-
acnA were
equivalent (data not shown), suggesting that carbon utilization
in both strains was proceeding through glycolysis and the acetate
kinase/phosphotransacetylase pathway at a similar rate. The
equivalent rate of acetic acid accumulation in strains 1457
and 1457-
acnA was also supported by NMR metabolomic analysis
(Table
3). If carbon flow through glycolysis were equivalent,
then it is reasonable to predict that the growth rate of the
wild-type and aconitase mutant strains would also be equivalent.
Surprisingly, the growth rate of strain 1457-
acnA was lower
than the growth rate of the isogenic wild-type strain, and this
was reflected in the temporal depletion of glucose (Fig.
1C).
This result was surprising because TCA cycle activity is repressed
during the exponential growth phase when nutrients are abundant;
thus, inactivating a repressed metabolic pathway should have
minimal consequences. Restoration of the growth rate and the
ability to catabolize acetate was accomplished by complementation
of the strain 1457-
acnA mutation with a plasmid (pMRS2) containing
the
acnA gene under the control of a P
spac promoter (Fig.
1A to D).
As a whole, these date demonstrate that
acnA was inactivated,
and this resulted in a metabolic block in the TCA cycle.
TCA cycle inactivation redirects carbon from growth into UDP-N-acetylglucosamine biosynthesis.
When grown in the presence of a rapidly catabolizable carbon
source, gram-positive bacteria repress the TCA cycle; hence,
there is an accumulation of acidic secondary metabolites (e.g.,
acetate) in the culture medium. Derepression of the TCA cycle
occurs upon depletion of the readily catabolizable carbon source(s)
and coincides with the depletion of acetate from the culture
medium. The processing of glucose through glycolysis and the
resulting accumulation of acetate during substrate-level phosphorylation
were equivalent in
S. epidermidis strains 1457 and 1457-
acnA;
hence, the lower growth rate of strain 1457-
acnA relative to
the wild-type strain was likely due to a redirection of carbon
and energy from growth into other cellular processes or metabolic
pathways. If carbon and/or energy were diverted from growth
to another metabolic pathway or process, then the number of
bacteria produced per unit of glucose consumed should be lower
in the aconitase mutant strain than in the wild-type strain.
Plotting the glucose concentrations in the culture medium as
a function of optical density at 600 nm for three independent
experiments (Fig.
2) confirmed that fewer bacteria are produced
per unit of glucose consumed by strain 1457-
acnA than by strain
1457. These data strongly suggest that carbon and/or energy
were diverted from growth into other cellular processes. To
determine the metabolic pathways into which carbon might be
redirected, we utilized NMR metabolomics to assess the metabolic
status of strains 1457 and 1457-
acnA in the exponential growth
phase (2 h) and the postexponential growth phase (6 h) (see
Fig. S1 and S2 in the supplemental material) (Tables
3 and
4).
As expected, TCA cycle inactivation decreased the intracellular
concentration of amino acids derived from TCA cycle intermediates
(Asn, Asp, Gln, and Glu) and increased accumulation of the PIA
biosynthetic precursor UDP-
N-acetylglucosamine. Interestingly,
TCA cycle inactivation resulted in an exponential-growth-phase
accumulation of branched-chain amino acids relative to the wild-type
strain (see Fig. S1 in the supplemental material) (Table
3).
In addition to increasing the carbon flow into branched-chain
amino acid biosynthesis, the presence of a high concentration
of glucono-1,5-lactone in strain 1457-
acnA suggests that inactivation
of the TCA cycle increased carbon flow into the pentose phosphate
pathway.
NMR metabolomics indicated that TCA cycle inactivation redirected
carbon into UDP-
N-acetylglucosamine biosynthesis (Tables
3 and
4). If carbon were being redirected into UDP-
N-acetylglucosamine
biosynthesis, then it is likely that transcription of genes
coding for the UDP-
N-acetylglucosamine biosynthetic enzymes
would be increased. To determine whether TCA cycle inactivation
altered the transcription of UDP-
N-acetylglucosamine biosynthetic
genes, we probed total RNA for
pgi (glucose-6-phosphate isomerase),
glmS (glucosamine-6-phosphate synthase),
glmM (phosphoglucosamine
mutase), and
glmU (UDP-
N-acetylglucosamine pyrophosphorylase)
(Fig.
3). Consistent with metabolomic data indicating an increased
intracellular concentration of fructose-6-phosphate, transcription
of
pgi was slightly increased in
S. epidermidis strain 1457-
acnA relative to strain 1457 during the exponential growth phase.
(Glucose-6-phosphate isomerase catalyzes the second step in
glycolysis, specifically, the reversible isomerization of glucose-6-phosphate
into fructose-6-phosphate.) Fructose-6-phosphate is the biosynthetic
precursor of UDP-
N-acetylglucosamine, whose biosynthesis is
encoded within the genes
glmS,
glmM, and
glmU. The exponential-growth-phase
mRNA levels of
glmS,
glmM, and
glmU were increased in strain
1457-
acnA relative to strain 1457. Taken together, these data
demonstrate that TCA cycle inactivation results in transcriptional
changes that redirect carbon into
N-acetylglucosamine biosynthesis.
In addition to providing biosynthetic intermediates, the TCA
cycle generates ATP and reducing potential; therefore, a metabolic
block in the TCA cycle will alter the energy status of the bacterium.
As an indicator of the energy status, the intracellular concentrations
of NAD
+, NADH, and ATP were determined for
S. epidermidis strains
1457 and 1457-
acnA. The intracellular concentration of ATP was
lower in the aconitase mutant strain relative to the wild-type
strain during both the exponential and postexponential growth
phases (Fig.
4C). This decreased ATP concentration was likely
due to decreased oxidative phosphorylation, as the intracellular
concentrations of NAD
+ and NADH were significantly (
P < 0.01)
lower in the aconitase mutant strain than in the wild-type strain
(Fig.
4A and B).
TCA cycle inactivation increases PIA accumulation.
To determine whether TCA cycle inactivation resulted in increased
synthesis of PIA, we assessed the relative amounts of cell-associated
PIA in the
acnA mutant, the complemented
acnA mutant, and the
wild-type strains using a PIA immunoblot assay (Fig.
5A and B).
In addition, to facilitate comparison of the effect of TCA cycle
inactivation on PIA accumulation with the inactivation of well-established
regulators (i.e., IcaR,
B, and SarA), we determined the relative
amounts of cell-associated PIA for isogenic strains that had
icaR,
sarA, or
sigB genetically inactivated. In agreement with
previous studies (
9,
10,
26,
35,
74), we observed that mutations
in the genes of positive regulators
sigB and
sarA decreased
PIA accumulation relative to the wild-type strain, while inactivation
of
icaR increased PIA accumulation (Fig.
5A and B). Surprisingly,
aconitase inactivation had a much greater effect on PIA synthesis
than did inactivation of the well-studied repressor IcaR (Fig.
5A and B). Complementation of the
acnA mutation restores PIA
accumulation to that seen in the parental strain (Fig.
5A and B).
In
B. subtilis, aconitase inactivation results in the accumulation
of citric acid, which is partially responsible for blocking
sporulation and causing a slight decrease in the growth rate
(
12). NMR metabolomics revealed an accumulation of citric acid
in the aconitase mutant strain relative to the wild-type strain
(see Fig. S1 and S2 in the supplemental material) (Tables
3 and
4), raising the possibility that the increased accumulation
of PIA and the decreased growth rate of
S. epidermidis strain
1457-
acnA relative to strain 1457 might be due to citric acid-induced
stress. To address these possibilities, we inactivated both
citrate synthase (
citZ) and isocitrate dehydrogenase (
citC)
in
S. epidermidis strain 1457 and assessed growth and assayed
for PIA accumulation (data not shown). Similar to the aconitase
mutant strain, the
citCZ double mutant dramatically increased
PIA accumulation. Additionally, the
citCZ double mutant had
a decreased growth rate relative to the wild-type strain, but
the growth rate was increased relative to strain 1457-
acnA (data
not shown), suggesting that citric acid accumulation was partially
responsible for the slower growth of the aconitase mutant. Taken
together, these data demonstrate that TCA cycle activity represses
S. epidermidis PIA accumulation and that this effect is independent
of citric acid.
TCA cycle activity represses icaADBC transcription.
TCA cycle inactivation alters the metabolic status of S. epidermidis (Fig. 1A to D and 3 and Tables 3 and 4), raising the possibility that an icaADBC transcriptional regulator could respond to the altered metabolic environment to increase icaADBC transcription. To determine whether the increased accumulation of PIA by the acnA mutant strain was due to altered icaADBC transcription, we examined icaADBC mRNA levels in S. epidermidis strains 1457 and 1457-acnA. In addition, icaADBC mRNA levels were determined for strain 1457 with mutations in sigB, sarA, or icaR. Consistent with the PIA immunoblot data (Fig. 5A and B), aconitase inactivation resulted in a very large increase in icaADBC transcription, or mRNA stability, relative to the isogenic wild-type strain (Fig. 6A and B), demonstrating that TCA cycle activity represses icaADBC transcription. In agreement with previous results, we observed that sigB and sarA inactivation repressed icaADBC transcription and that icaR inactivation derepressed icaADBC transcription (9, 11, 26). Interestingly, the extent of derepression in the 1457-acnA mutant strain was dramatically higher than seen in an isogenic icaR mutant (Fig. 6A and B), suggesting TCA cycle activity has a greater role in regulating icaADBC transcription than does IcaR. These data demonstrate that, like regulation of the lac operon, icaADBC transcription is regulated by a catabolic process, specifically, the TCA cycle.
TCA cycle inactivation alters transcription of icaR, sarA, and sigB.
As stated, transcription of
icaADBC requires at least two positive
effectors, SarA and
B, and one negative regulator, IcaR. The
dramatic increase in
icaADBC mRNA levels in the aconitase mutant
strain relative to the wild-type strain could be due to an increased
number of positive effectors or a decreased number of negative
effectors. To determine whether aconitase inactivation altered
transcription of the known regulators of
icaADBC transcription,
we probed total RNA isolated throughout the growth cycle for
changes in the transcription of
sigB,
sarA, and
icaR (Fig.
7).
Surprisingly, aconitase inactivation increased transcription
or mRNA stability of both positive regulators
sigB and
sarA and the negative regulator
icaR. These data suggest that TCA
cycle inactivation can alter the mRNA levels of the known regulators
of PIA synthesis; however, they fail to establish that these
regulators are involved in TCA cycle-mediated regulation of
PIA synthesis. To determine whether IcaR, SarA, or
B is regulating
PIA synthesis in response to TCA cycle-associated metabolic
changes,
icaR,
sarA, and
sigB regulatory mutants of strain 1457
were incubated with 400 µM of the aconitase inhibitor
fluorocitric acid, and PIA accumulation was assessed relative
to the parental strain 1457 (Fig.
8.) The addition of fluorocitric
acid to the culture medium of
S. epidermidis strains 1457-
sigB and 1457-
icaR significantly (
P < 0.01) increased the accumulation
of PIA relative to the untreated control cultures. In strain
1457-
sarA, the accumulation of PIA was similar irrespective
of the presence of fluorocitric acid in the culture medium (
P > 0.05). Overall, these data suggest that TCA cycle-mediated
derepression of
ica transcription and PIA synthesis occur independently
of IcaR and
B. Furthermore, these data confirm that PIA synthesis
requires SarA (
10,
74) and at least one additional TCA cycle-responsive
negative regulator.

DISCUSSION
Metabolic effect of TCA cycle activity on PIA biosynthesis.
Glycolysis is the catabolic pathway that converts glucose into
pyruvate, with the catabolic fate of pyruvate being determined
by the availability of oxygen. Interestingly, the rate of glucose
utilization by the wild-type
S. epidermidis strain 1457 appears
greater than the rate by strain 1457-
acnA (Fig.
1C); however,
these data fail to account for the number of bacteria in the
medium. When this is taken into account, glucose utilization
was greater in strain 1457-
acnA than in strain 1457 (Fig.
2),
suggesting that carbon flow through glycolysis might be greater
in a TCA cycle mutant. If the amount of carbon flowing through
glycolysis were greater in a TCA cycle mutant than in the parental
strain, then the amount of acetate in the culture medium at
the time when glucose was depleted should be greater in the
mutant. Glucose was depleted in the wild-type and complemented
strains after 5 h of growth; however, in strain 1457-
acnA, glucose
was depleted after 7 h of growth (Fig.
1C). Upon depletion of
glucose, the concentrations of acetate in the culture medium
were similar (14 to 16 mM) for all strains (Fig.
1D), suggesting
that carbon flow through glycolysis was similar in the aconitase
mutant and the wild-type strain. Additionally, because the concentrations
of acetate were below 24 mM (if all glucose is processed through
the glycolytic pathway, then a 2:1 stoichiometry of acetate
to glucose should be maintained), the data confirm that carbon
are flowing into other pathways. Consistent with these data,
NMR metabolomics indicated that the exponential-growth-phase
concentrations of acetic acid in strains 1457 and 1457-
acnA were similar (Table
3). In addition to glycolysis, another major
pathway staphylococci use for glucose catabolism is the pentose
phosphate pathway (
8,
70). The presence of glucono-1,5-lactone
in the NMR metabolomic data (Table
3) suggests that carbon flow
through the pentose phosphate pathway is increased in the TCA
cycle mutant strain relative to the wild-type strain. One function
of the pentose phosphate pathway is to provide the five-carbon
intermediate for purine biosynthesis; hence, the increased carbon
flow through the pentose phosphate pathway is likely linked
to the decreased intracellular concentration of ATP in strain
1457-
acnA relative to strain 1457 (Fig.
3). (De novo biosynthesis
of ATP requires 5-phosphoribosyl-1-pyrophosphate. An important
function of the pentose phosphate pathway is to provide biosynthetic
intermediates for purine biosynthesis, namely, ribose-5-phosphate
that is converted into 5-phosphoribosyl-1-pyrophosphate.)
NMR metabolomic data revealed an increased intracellular concentration of fructose-6-phosphate in the TCA cycle mutant relative to the wild-type strain (Table 3). Fructose-6-phosphate can undergo a transamination reaction to generate glucosamine-6-phosphate, a reaction catalyzed by glucosamine-6-phosphate synthase (glmS; EC 2.6.1.16). Phosphoglucosamine mutase (glmM; EC 5.4.2.10) catalyzes the reversible isomerization glucosamine-6-phosphate to glucosamine-1-phosphate. Glucosamine-1-phophaste is the substrate for the bifunctional enzyme UDP-N-acetylglucosamine pyrophosphorylase (glmU; EC 2.7.7.23 and EC 2.3.1.157) that catalyzes the acetylation and UTP-dependent activation of glucosamine-1-phosphate to generate UDP-N-acetylglucosamine. NMR metabolomics confirmed that S. epidermidis strain 1457-acnA has a greater intracellular concentration of UDP-N-acetylglucosamine than strain 1457 does. In addition, transcription of glmS, glmM, and glmU is increased more during the exponential growth phase in the TCA cycle mutant than in the wild-type strain (Fig. 3). In total, these data demonstrate that TCA cycle inactivation increased the availability of the PIA monomer, UDP-activated N-acetylglucosamine and that this was partially due to transcriptional derepression of N-acetylglucosamine biosynthetic genes.
In addition to PIA synthesis, UDP-N-acetylglucosamine is critical for biosynthesis of the cell wall components teichoic acid and peptidoglycan. Inactivation of aconitase in S. epidermidis decreased the growth rate (Fig. 1B) and the number of bacteria produced per unit of glucose (Fig. 2), suggesting that UDP-N-acetylglucosamine was redirected from cell wall biosynthesis to PIA synthesis (Fig. 5A). Thus, the decreased growth rate of the aconitase mutant strain was likely due to a combination of increased competition for substrate (i.e., UDP-N-acetylglucosamine) by PIA biosynthetic enzymes and an accumulation of citric acid.
Regulatory effect of TCA cycle activity on PIA biosynthesis.
Two common mechanisms by which bacteria control carbon flow are feedback inhibition of enzyme activity and regulation of enzyme synthesis. Undoubtedly, some of the metabolic changes arising from TCA cycle inactivation are the result of feedback inhibition of enzyme activity; however, by definition, the derepression of icaADBC transcription (Fig. 6A and B) must be at the regulatory level. Although the prospect that TCA cycle enzymes directly regulate icaADBC transcription is a possibility, it is more likely that regulation is being mediated by regulatory proteins responding to changes in the metabolic status of the bacteria. Metabolic regulation was one of the first bacterial regulatory modalities identified, resulting in thousands of studies addressing all aspects of regulation. This long history of research into metabolic regulation has identified a large number of regulatory proteins capable of responding to changes in the intracellular concentrations of molecules associated with TCA cycle activity, such as NADH (e.g., Rex [4], NmrA [39], and CcpA [21]), citric acid (CcpC [30, 33]), glutamate (GadX and GadW [75]), branched-chain amino acids (CodY [61]), and ATP (KinA [69]). These observations lead us to hypothesize that a regulatory protein or proteins respond to TCA cycle-associated metabolites and regulate icaADBC transcription and PIA synthesis.
TCA cycle inactivation increased the transcription or mRNA stability of the known regulators of icaADBC transcription, specifically, sigB, sarA, and icaR (Fig. 7). These data raise the possibility that TCA cycle-induced alterations in the metabolic status of the bacterium might be "sensed" by
B, SarA, or IcaR. Incubation of S. epidermidis strain 1457-sigB with a low concentration of the TCA cycle inhibitor fluorocitric acid restored PIA synthesis to wild-type levels (Fig. 8). This fluorocitrate-induced derepression of PIA synthesis in the sigB mutant strain is similar to that observed in an S. epidermidis rsbU mutant strain (RsbU is an activator of
B) treated with a PIA synthesis-stimulating concentration of ethanol (34). In that study, the authors found that ethanol could restore cell-associated PIA accumulation in an rsbU mutant strain to a level equivalent to that of the nonstimulated wild-type strain. Because ethanol is an inhibitor of TCA cycle activity (6, 37), we hypothesize that the PIA synthesis-stimulating properties of ethanol may be due to its TCA cycle inhibitory properties.
Inactivation of sarA in S. epidermidis dramatically decreases icaADBC transcription (74) and PIA accumulation (26, 74) and results in a biofilm-negative phenotype (10). Because SarA is thought to be essential for PIA synthesis (74), the more likely outcome of incubating S. epidermidis strain 1457-sarA with fluorocitric acid would be equivalent PIA accumulation between the wild-type and sarA mutant strains. As expected, the amount of PIA produced by strain 1457-sarA was similar irrespective of the presence of fluorocitric acid (Fig. 8). These data are consistent with SarA being essential for PIA synthesis and/or being required for responding to TCA cycle-associated signals.
TCA cycle inactivation increased transcription or mRNA stability of icaR relative to the wild-type strain (Fig. 7). IcaR is a transcriptional repressor of icaADBC that was originally hypothesized to be involved in environmental regulation of PIA synthesis (9). For these reasons, IcaR appeared to be a possible candidate for responding to TCA cycle-induced metabolic changes. If IcaR were responding to TCA cycle-associated metabolic changes, then in an icaR mutant background, the synthesis of PIA should be unaffected by the presence of fluorocitric acid. Growth of strain 1457-icaR in the presence of a low concentration of fluorocitric acid significantly increased the accumulation of PIA (Fig. 8), demonstrating that a second repressor is involved in regulating PIA synthesis. It is likely that this second repressor is responding to TCA cycle-associated metabolic signals.
NMR metabolomics (Table 3) indicated that the intracellular concentrations of branched-chain amino acids were greater in the aconitase mutant strain than in the wild-type strain. In gram-positive bacteria, the intracellular concentrations of branched-chain amino acids control the expression of numerous genes, a mechanism requiring the CodY regulatory protein (25, 61, 66, 72). The affinity of CodY for its operator site is enhanced in response to high intracellular concentrations of GTP and branched-chain amino acids (54, 61). The more likely explanations for our data are that CodY is an activator of icaADBC transcription, CodY-mediated repression is not functioning in S. epidermidis during the exponential growth phase, or a positive effector, potentially SarA, can overcome CodY-mediated repression. We recently demonstrated that CodY is a repressor of PIA synthesis in the closely related species S. aureus (45); thus, it seems unlikely that CodY is an activator of icaADBC transcription in S. epidermidis. Investigations are under way to determine the function of CodY in regulating S. epidermidis PIA synthesis.
In gram-positive bacteria, carbon catabolite repression is primarily mediated by CcpA (28). Recently, CcpA was shown to activate transcription of icaADBC and increase the accumulation of PIA in S. aureus (60). In B. subtilis, CcpA regulatory activity is controlled by interactions with phosphorylated HPr or Crh and fructose-1,6,-bisphosphate or glucose-6-phosphate (67). NMR analysis indicated that TCA cycle inactivation increased the intracellular concentration of fructose-6-phosphate (Table 3). Fructose-6-phosphate is the biosynthetic precursor of UDP-N-acetylglucosamine. In addition to its importance in PIA biosynthesis, fructose-6-phosphate can be reversibly isomerized to glucose-6-phosphate by glucose-6-phosphate isomerase, resulting in CcpA activation. Taken together, these data lead us to hypothesize that TCA cycle inactivation increases CcpA-mediated activation of icaADBC.
Conclusion.
TCA cycle activity is repressed during the exponential growth phase; however, a basal level of activity is present. As evidenced by the data in this study, disruption of this basal activity can have pronounced metabolic consequences. TCA cycle activity is regulated by the availability of nutrients, oxygen, and iron (8, 62, 65, 71, 76) and by certain stress-inducing stimuli, such as heat, ethanol, and antibiotics (6, 36, 73); thus, numerous external conditions can interfere with the basal TCA cycle activity and produce metabolic changes. The linkage of TCA cycle activity and exopolysaccharide synthesis and the susceptibility of the TCA cycle to environmental inactivation lead us to speculate that one mechanism by which staphylococci perceive external environmental change is through alterations in TCA cycle activity. Thus, we hypothesize that the TCA cycle acts as a novel signal transduction pathway to translate external stimuli/conditions into intracellular signals that can stimulate or repress the activity of regulatory proteins like CodY and CcpA.

ACKNOWLEDGMENTS
This article is a contribution of the University of Nebraska
Agricultural Research Division, supported in part by funds provided
through the Hatch Act, the National Institute of General Medical
Sciences (GM076585), and the American Heart Association (0760005Z)
to G.A.S. and the American Heart Association (0860033Z) to R.P.

FOOTNOTES
* Corresponding author. Mailing address: Department of Veterinary and Biomedical Sciences, University of Nebraska—Lincoln, 155 VBS, Fair St. and East Campus Loop, Lincoln, NE 68583-0905. Phone: (402) 472-6063. Fax: (402) 472-9690. E-mail:
gsomerville3{at}unl.edu 
Published ahead of print on 26 September 2008. 
Supplemental material for this article may be found at http://jb.asm.org/. 

REFERENCES
1 - Baughn, A. D., and M. H. Malamy. 2002. A mitochondrial-like aconitase in the bacterium Bacteroides fragilis: implications for the evolution of the mitochondrial Krebs cycle. Proc. Natl. Acad. Sci. USA 99:4662-4667.[Abstract/Free Full Text]
2 - Begun, J., J. M. Gaiani, H. Rohde, D. Mack, S. B. Calderwood, F. M. Ausubel, and C. D. Sifri. 2007. Staphylococcal biofilm exopolysaccharide protects against Caenorhabditis elegans immune defenses. PLoS Pathog. 3:e57.[CrossRef][Medline]
3 - Bischoff, M., P. Dunman, J. Kormanec, D. Macapagal, E. Murphy, W. Mounts, B. Berger-Bächi, and S. Projan. 2004. Microarray-based analysis of the Staphylococcus aureus
B regulon. J. Bacteriol. 186:4085-4099.[Abstract/Free Full Text] 4 - Brekasis, D., and M. S. Paget. 2003. A novel sensor of NADH/NAD+ redox poise in Streptomyces coelicolor A3(2). EMBO J. 22:4856-4865.[CrossRef][Medline]
5 - Brückner, R. 1997. Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol. Lett. 151:1-8.[Medline]
6 - Chatterjee, I., G. A. Somerville, C. Heilmann, H. G. Sahl, H. H. Maurer, and M. Herrmann. 2006. Very low ethanol concentrations affect the viability and growth recovery in post-stationary-phase Staphylococcus aureus populations. Appl. Environ. Microbiol. 72:2627-2636.[Abstract/Free Full Text]
7 - Cho, S. H., K. Naber, J. Hacker, and W. Ziebuhr. 2002. Detection of the icaADBC gene cluster and biofilm formation in Staphylococcus epidermidis isolates from catheter-related urinary tract infections. Int. J. Antimicrob. Agents 19:570-575.[CrossRef][Medline]
8 - Collins, F. M., and J. Lascelles. 1962. The effect of growth conditions on oxidative and dehydrogenase activity in Staphylococcus aureus. J. Gen. Microbiol. 29:531-535.[Abstract/Free Full Text]
9 - Conlon, K. M., H. Humphreys, and J. P. O'Gara. 2002. icaR encodes a transcriptional repressor involved in environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis. J. Bacteriol. 184:4400-4408.[Abstract/Free Full Text]
10 - Conlon, K. M., H. Humphreys, and J. P. O'Gara. 2004. Inactivations of rsbU and sarA by IS256 represent novel mechanisms of biofilm phenotypic variation in Staphylococcus epidermidis. J. Bacteriol. 186:6208-6219.[Abstract/Free Full Text]
11 - Conlon, K. M., H. Humphreys, and J. P. O'Gara. 2002. Regulation of icaR gene expression in Staphylococcus epidermidis. FEMS Microbiol. Lett. 216:171-177.[CrossRef][Medline]
12 - Craig, J. E., M. J. Ford, D. C. Blaydon, and A. L. Sonenshein. 1997. A null mutation in the Bacillus subtilis aconitase gene causes a block in Spo0A-phosphate-dependent gene expression. J. Bacteriol. 179:7351-7359.[Abstract/Free Full Text]
13 - Cramton, S. E., M. Ulrich, F. Götz, and G. Döring. 2001. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect. Immun. 69:4079-4085.[Abstract/Free Full Text]
14 - Cui, Q., I. A. Lewis, A. D. Hegeman, M. E. Anderson, J. Li, C. F. Schulte, W. M. Westler, H. R. Eghbalnia, M. R. Sussman, and J. L. Markley. 2008. Metabolite identification via the Madison Metabolomics Consortium Database. Nat. Biotechnol. 26:162-164.[CrossRef][Medline]
15 - Dean, B. A., R. E. Williams, F. Hall, and J. Corse. 1973. Phage typing of coagulase-negative staphylococci and micrococci. J. Hyg. (London) 71:261-270.[Medline]
16 - Deighton, M., and R. Borland. 1993. Regulation of slime production in Staphylococcus epidermidis by iron limitation. Infect. Immun. 61:4473-4479.[Abstract/Free Full Text]
17 - Delaglio, F., S. Grzesiek, G. W. Vuister, G. Zhu, J. Pfeifer, and A. Bax. 1995. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6:277-293.[Medline]
18 - Dobinsky, S., K. Kiel, H. Rohde, K. Bartscht, J. K. Knobloch, M. A. Horstkotte, and D. Mack. 2003. Glucose-related dissociation between icaADBC transcription and biofilm expression by Staphylococcus epidermidis: evidence for an additional factor required for polysaccharide intercellular adhesin synthesis. J. Bacteriol. 185:2879-2886.[Abstract/Free Full Text]
19 - Foster, T. J. 1998. Molecular genetic analysis of staphylococcal virulence. Methods Microbiol. 27:433-454.
20 - Garrett, D. S., R. Powers, A. M. Gronenborn, and G. M. Clore. 1991. A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams. J. Magn. Reson. 95:214-220.
21 - Gaudu, P., G. Lamberet, S. Poncet, and A. Gruss. 2003. CcpA regulation of aerobic and respiration growth in Lactococcus lactis. Mol. Microbiol. 50:183-192.[CrossRef][Medline]
22 - Götz, F. 2002. Staphylococcus and biofilms. Mol. Microbiol. 43:1367-1378.[CrossRef][Medline]
23 - Gracia, E., A. Fernández, P. Conchello, J. L. Alabart, M. Pérez, and B. Amorena. 1999. In vitro development of Staphylococcus aureus biofilms using slime-producing variants and ATP-bioluminescence for automated bacterial quantification. Luminescence 14:23-31.[CrossRef][Medline]
24 - Greene, C., D. McDevitt, P. Francois, P. E. Vaudaux, D. P. Lew, and T. J. Foster. 1995. Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin-binding proteins and studies on the expression of fnb genes. Mol. Microbiol. 17:1143-1152.[CrossRef][Medline]
25 - Guédon, E., P. Serror, S. D. Ehrlich, P. Renault, and C. Delorme. 2001. Pleiotropic transcriptional repressor CodY senses the intracellular pool of branched-chain amino acids in Lactococcus lactis. Mol. Microbiol. 40:1227-1239.[CrossRef][Medline]
26 - Handke, L. D., S. R. Slater, K. M. Conlon, S. T. O'Donnell, M. E. Olson, K. A. Bryant, M. E. Rupp, J. P. O'Gara, and P. D. Fey. 2007. SigmaB and SarA independently regulate polysaccharide intercellular adhesin production in Staphylococcus epidermidis. Can. J. Microbiol. 53:82-91.[CrossRef][Medline]
27 - Heilmann, C., O. Schweitzer, C. Gerke, N. Vanittanakom, D. Mack, and F. Götz. 1996. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol. Microbiol. 20:1083-1091.[Medline]
28 - Henkin, T. M., F. J. Grundy, W. L. Nicholson, and G. H. Chambliss. 1991. Catabolite repression of alpha-amylase gene expression in Bacillus subtilis involves a trans-acting gene product homologous to the Escherichia coli lacI and galR repressors. Mol. Microbiol. 5:575-584.[CrossRef][Medline]
29 - Jeng, W. Y., T. P. Ko, C. I. Liu, R. T. Guo, C. L. Liu, H. L. Shr, and A. H. Wang. 2008. Crystal structure of IcaR, a repressor of the TetR family implicated in biofilm formation in Staphylococcus epidermidis. Nucleic Acids Res. 36:1567-1577.[Abstract/Free Full Text]
30 - Jourlin-Castelli, C., N. Mani, M. M. Nakano, and A. L. Sonenshein. 2000. CcpC, a novel regulator of the LysR family required for glucose repression of the citB gene in Bacillus subtilis. J. Mol. Biol. 295:865-878.[CrossRef][Medline]
31 - Kanehisa, M., M. Araki, S. Goto, M. Hattori, M. Hirakawa, M. Itoh, T. Katayama, S. Kawashima, S. Okuda, T. Tokimatsu, and Y. Yamanishi. 2008. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 36:D480-484.[Abstract/Free Full Text]
32 - Karp, P. D., C. A. Ouzounis, C. Moore-Kochlacs, L. Goldovsky, P. Kaipa, D. Ahren, S. Tsoka, N. Darzentas, V. Kunin, and N. Lopez-Bigas. 2005. Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res. 33:6083-6089.[Abstract/Free Full Text]
33 - Kim, H. J., A. Roux, and A. L. Sonenshein. 2002. Direct and indirect roles of CcpA in regulation of Bacillus subtilis Krebs cycle genes. Mol. Microbiol. 45:179-190.[CrossRef][Medline]
34 - Knobloch, J. K., K. Bartscht, A. Sabottke, H. Rohde, H. H. Feucht, and D. Mack. 2001. Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress. J. Bacteriol. 183:2624-2633.[Abstract/Free Full Text]
35 - Knobloch, J. K., S. Jager, M. A. Horstkotte, H. Rohde, and D. Mack. 2004. RsbU-dependent regulation of Staphylococcus epidermidis biofilm formation is mediated via the alternative sigma factor
B by repression of the negative regulator gene icaR. Infect. Immun. 72:3838-3848.[Abstract/Free Full Text] 36 - Kohanski, M. A., D. J. Dwyer, B. Hayete, C. A. Lawrence, and J. J. Collins. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810.[CrossRef][Medline]
37 - Kornmann, H., P. Duboc, P. Niederberger, I. Marison, and U. von Stockar. 2003. Influence of residual ethanol concentration on the growth of Gluconacetobacter xylinus I 2281. Appl. Microbiol. Biotechnol. 62:168-173.[CrossRef][Medline]
38 - Kozitskaya, S., S. H. Cho, K. Dietrich, R. Marre, K. Naber, and W. Ziebuhr. 2004. The bacterial insertion sequence element IS256 occurs preferentially in nosocomial Staphylococcus epidermidis isolates: association with biofilm formation and resistance to aminoglycosides. Infect. Immun. 72:1210-1215.[Abstract/Free Full Text]
39 - Lamb, H. K., K. Leslie, A. L. Dodds, M. Nutley, A. Cooper, C. Johnson, P. Thompson, D. K. Stammers, and A. R. Hawkins. 2003. The negative transcriptional regulator NmrA discriminates between oxidized and reduced dinucleotides. J. Biol. Chem. 278:32107-32114.[Abstract/Free Full Text]
40 - Lauble, H., M. C. Kennedy, M. H. Emptage, H. Beinert, and C. D. Stout. 1996. The reaction of fluorocitrate with aconitase and the crystal structure of the enzyme-inhibitor complex. Proc. Natl. Acad. Sci. USA 93:13699-13703.[Abstract/Free Full Text]
41 - Lowry, O. H., N. J. Rosebrough, L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:267-275.
42 - Mack, D., W. Fischer, A. Krokotsch, K. Leopold, R. Hartmann, H. Egge, and R. Laufs. 1996. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J. Bacteriol. 178:175-183.[Abstract/Free Full Text]
43 - Mack, D., N. Siemssen, and R. Laufs. 1992. Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion. Infect. Immun. 60:2048-2057.[Abstract/Free Full Text]
44 - Maira-Litrán, T., A. Kropec, C. Abeygunawardana, J. Joyce, G. Mark III, D. A. Goldmann, and G. B. Pier. 2002. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect. Immun. 70:4433-4440.[Abstract/Free Full Text]
45 - Majerczyk, C. D., M. R. Sadykov, T. T. Luong, C. Lee, G. A. Somerville, and A. L. Sonenshein. 2008. Staphylococcus aureus CodY negatively regulates virulence gene expression. J. Bacteriol. 190:2257-2265.[Abstract/Free Full Text]
46 - McCombie, H., and B. C. Saunders. 1946. Fluoroacetates and allied compounds. Nature 158:382-385.[CrossRef]
47 - Mekalanos, J. J. 1992. Environmental signals controlling expression of virulence determinants in bacteria. J. Bacteriol. 174:1-7.[Free Full Text]
48 - National Nosocomial Infections Surveillance. 2004. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32:470-485.[CrossRef][Medline]
49 - Novick, R. P. 1991. Genetic systems in staphylococci. Methods Enzymol. 204:587-636.[Medline]
50 - Olson, M. E., K. L. Garvin, P. D. Fey, and M. E. Rupp. 2006. Adherence of Staphylococcus epidermidis to biomaterials is augmented by PIA. Clin. Orthop. Relat. Res. 451:21-24.[CrossRef][Medline]
51 - Projan, S. J., and G. L. Archer. 1989. Mobilization of the relaxable Staphylococcus aureus plasmid pC221 by the conjugative plasmid pGO1 involves three pC221 loci. J. Bacteriol. 171:1841-1845.[Abstract/Free Full Text]
52 - Rachid, S., K. Ohlsen, U. Wallner, J. Hacker, M. Hecker, and W. Ziebuhr. 2000. Alternative transcription factor
B is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate. J. Bacteriol. 182:6824-6826.[Abstract/Free Full Text] 53 - Rachid, S., K. Ohlsen, W. Witte, J. Hacker, and W. Ziebuhr. 2000. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob. Agents Chemother. 44:3357-3363.[Abstract/Free Full Text]
54 - Ratnayake-Lecamwasam, M., P. Serror, K. W. Wong, and A. L. Sonenshein. 2001. Bacillus subtilis CodY represses early-stationary-phase genes by sensing GTP levels. Genes Dev. 15:1093-1103.[Abstract/Free Full Text]
55 - Rupp, M. E. 1997. Infections of intravascular catheters and vascular devices, p. 379-399. In K. B. Crossley and G. L. Archer (ed.), The staphylococci in human disease. Churchill-Livingstone, New York, NY.
56 - Rupp, M. E., J. S. Ulphani, P. D. Fey, K. Bartscht, and D. Mack. 1999. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect. Immun. 67:2627-2632.[Abstract/Free Full Text]
57 - Rupp, M. E., J. S. Ulphani, P. D. Fey, and D. Mack. 1999. Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect. Immun. 67:2656-2659.[Abstract/Free Full Text]
58 - Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
59 - Schenk, S., and R. A. Laddaga. 1992. Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol. Lett. 73:133-138.[Medline]
60 - Seidl, K., C. Goerke, C. Wolz, D. Mack, B. Berger-Bächi, and M. Bischoff. 2008. Staphylococcus aureus CcpA affects biofilm formation. Infect. Immun. 76:2044-2050.[Abstract/Free Full Text]
61 - Shivers, R. P., and A. L. Sonenshein. 2004. Activation of the Bacillus subtilis global regulator CodY by direct interaction with branched-chain amino acids. Mol. Microbiol. 53:599-611.[CrossRef][Medline]
62 - Somerville, G., C. A. Mikoryak, and L. Reitzer. 1999. Physiological characterization of Pseudomonas aeruginosa during exotoxin A synthesis: glutamate, iron limitation, and aconitase activity. J. Bacteriol. 181:1072-1078.[Abstract/Free Full Text]
63 - Somerville, G. A., S. B. Beres, J. R. Fitzgerald, F. R. DeLeo, R. L. Cole, J. S. Hoff, and J. M. Musser. 2002. In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence. J. Bacteriol. 184:1430-1437.[Abstract/Free Full Text]
64 - Somerville, G. A., M. S. Chaussee, C. I. Morgan, J. R. Fitzgerald, D. W. Dorward, L. J. Reitzer, and J. M. Musser. 2002. Staphylococcus aureus aconitase inactivation unexpectedly inhibits post-exponential-phase growth and enhances stationary-phase survival. Infect. Immun. 70:6373-6382.[Abstract/Free Full Text]
65 - Somerville, G. A., B. Saïd-Salim, J. M. Wickman, S. J. Raffel, B. N. Kreiswirth, and J. M. Musser. 2003. Correlation of acetate catabolism and growth yield in Staphylococcus aureus: implications for host-pathogen interactions. Infect. Immun. 71:4724-4732.[Abstract/Free Full Text]
66 - Sonenshein, A. L. 2005. CodY, a global regulator of stationary phase and virulence in Gram-positive bacteria. Curr. Opin. Microbiol. 8:203-207.[CrossRef][Medline]
67 - Sonenshein, A. L. 2007. Control of key metabolic intersections in Bacillus subtilis. Nat. Rev. Microbiol. 5:917-927.[CrossRef][Medline]
68 - Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.[CrossRef][Medline]
69 - Stephenson, K., and J. A. Hoch. 2001. PAS-A domain of phosphorelay sensor kinase A: a catalytic ATP-binding domain involved in the initiation of development in Bacillus subtilis. Proc. Natl. Acad. Sci. USA 98:15251-15256.[Abstract/Free Full Text]
70 - Strasters, K. C., and K. C. Winkler. 1963. Carbohydrate metabolism of Staphylococcus aureus. J. Gen. Microbiol. 33:213-229.[Abstract/Free Full Text]
71 - Throup, J. P., F. Zappacosta, R. D. Lunsford, R. S. Annan, S. A. Carr, J. T. Lonsdale, A. P. Bryant, D. McDevitt, M. Rosenberg, and M. K. Burnham. 2001. The srhSR gene pair from Staphylococcus aureus: genomic and proteomic approaches to the identification and characterization of gene function. Biochemistry 40:10392-10401.[CrossRef][Medline]
72 - Tojo, S., T. Satomura, K. Morisaki, J. Deutscher, K. Hirooka, and Y. Fujita. 2005. Elaborate transcription regulation of the Bacillus subtilis ilv-leu operon involved in the biosynthesis of branched-chain amino acids through global regulators of CcpA, CodY and TnrA. Mol. Microbiol. 56:1560-1573.[Medline]
73 - Tomlins, R. I., M. D. Pierson, and Z. J. Ordal. 1971. Effect of thermal injury on the TCA cycle enzymes of Staphylococcus aureus MF 31 and Salmonella typhimurium 7136. Can. J. Microbiol. 17:759-765.[Medline]
74 - Tormo, M. A., M. Martí, J. Valle, A. C. Manna, A. L. Cheung, I. Lasa, and J. R. Penadés. 2005. SarA is an essential positive regulator of Staphylococcus epidermidis biofilm development. J. Bacteriol. 187:2348-2356.[Abstract/Free Full Text]
75 - Tramonti, A., M. De Canio, I. Delany, V. Scarlato, and D. De Biase. 2006. Mechanisms of transcription activation exerted by GadX and GadW at the gadA and gadBC gene promoters of the glutamate-based acid resistance system in Escherichia coli. J. Bacteriol. 188:8118-8127.[Abstract/Free Full Text]
76 - Varghese, S., Y. Tang, and J. A. Imlay. 2003. Contrasting sensitivities of Escherichia coli aconitases A and B to oxidation and iron depletion. J. Bacteriol. 185:221-230.[Abstract/Free Full Text]
77 - von Eiff, C., G. Peters, and C. Heilmann. 2002. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect. Dis. 2:677-685.[CrossRef][Medline]
78 - Vuong, C., J. B. Kidder, E. R. Jacobson, M. Otto, R. A. Proctor, and G. A. Somerville. 2005. Staphylococcus epidermidis polysaccharide intercellular adhesin production significantly increases during tricarboxylic acid cycle stress. J. Bacteriol. 187:2967-2973.[Abstract/Free Full Text]
79 - Vuong, C., S. Kocianova, J. M. Voyich, Y. Yao, E. R. Fischer, F. R. Deleo, and M. Otto. 2004. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J. Biol. Chem. 24:54881-54886.
80 - Vuong, C., J. M. Voyich, E. R. Fischer, K. R. Braughton, A. R. Whitney, F. R. DeLeo, and M. Otto. 2004. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 6:269-275.[CrossRef][Medline]
81 - Wu, S., H. de Lencastre, and A. Tomasz. 1996. Sigma-B, a putative operon encoding alternate sigma factor of Staphylococcus aureus RNA polymerase: molecular cloning and DNA sequencing. J. Bacteriol. 178:6036-6042.[Abstract/Free Full Text]
82 - Xu, L., H. Li, C. Vuong, V. Vadyvaloo, J. Wang, Y. Yao, M. Otto, and Q. Gao. 2006. Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis. Infect. Immun. 74:488-496.[Abstract/Free Full Text]
83 - Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.[CrossRef][Medline]
84 - Ziebuhr, W., C. Heilmann, F. Götz, P. Meyer, K. Wilms, E. Straube, and J. Hacker. 1997. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect. Immun. 65:890-896.[Abstract]
Journal of Bacteriology, December 2008, p. 7621-7632, Vol. 190, No. 23
0021-9193/08/$08.00+0 doi:10.1128/JB.00806-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Zhu, Y., Xiong, Y. Q., Sadykov, M. R., Fey, P. D., Lei, M. G., Lee, C. Y., Bayer, A. S., Somerville, G. A.
(2009). Tricarboxylic Acid Cycle-Dependent Attenuation of Staphylococcus aureus In Vivo Virulence by Selective Inhibition of Amino Acid Transport. Infect. Immun.
77: 4256-4264
[Abstract]
[Full Text]
-
Somerville, G. A., Proctor, R. A.
(2009). At the Crossroads of Bacterial Metabolism and Virulence Factor Synthesis in Staphylococci. Microbiol. Mol. Biol. Rev.
73: 233-248
[Abstract]
[Full Text]